Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116518 | SCV000150467 | benign | not specified | 2019-04-24 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000116518 | SCV000331730 | benign | not specified | 2015-06-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116518 | SCV000524679 | benign | not specified | 2016-12-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Center for Pediatric Genomic Medicine, |
RCV000514339 | SCV000610384 | likely benign | not provided | 2017-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081343 | SCV000656729 | benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316297 | SCV000849526 | benign | Inborn genetic diseases | 2016-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000116518 | SCV001476217 | benign | not specified | 2020-03-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985269 | SCV004753304 | benign | CACNA1A-related disorder | 2019-06-14 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Breakthrough Genomics, |
RCV000514339 | SCV005209543 | likely benign | not provided | criteria provided, single submitter | not provided |